SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hedera is a decentralized public network where developers can build secure, fair applications with near real-time consensus. The platform is owned and governed by a council of global innovators including Avery Dennison, Boeing, Deutsche Telekom, DLA Piper, FIS (WorldPay), Google, IBM, LG Electronics, Magalu, Nomura, Swirlds, Tata Communications, University College London (UCL), Wipro, and Zain Group.   The Hedera Consensus Service (HCS) acts as a trust layer for any application or permissioned network and allows for the creation of an immutable and verifiable log of messages. Application messages are submitted to the Hedera network for consensus, given a trusted timestamp, and fairly ordered. Use HCS to track assets across a supply chain, create auditable logs of events in an advertising platform, or even use it as a decentralized ordering service.

Hedera Hashgraph

Hedera Hashgraph (HBAR) is actively trending as the community debates its future, ignited by news of FedEx joining the Hedera Governing Council and reports of the U.S. Military adopting its quantum-secure technology for drones. While many highlight its real-world utility and undervalued status with strong bullish sentiment, a vocal segment remains bearish, labeling it a 'scam' amidst broader market uncertainty and predicting further dips.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix is trending with high investor anticipation for its pivotal SOL-1 Phase 3 data readout for wet AMD on Tuesday, as a key new commercial leadership hire and ongoing Sanofi acquisition rumors fuel optimism for a significant move and potential short squeeze.

This is a legacy token commemorating the pseudonym Satoshi Nakamoto.

Satoshi Nakamoto

$SATOSHI is trending as its community highlights its unique position as the decentralized tokenization of the Satoshi Nakamoto name, celebrating it as the ultimate narrative and identity of the entire crypto industry. Holders believe it offers an unparalleled opportunity, representing the "Bitcoin of memes" with limitless cultural and financial upside.

"What's Updog?" is a Community Led token.

UpDog

UPDOG CRYPTO is generating buzz through its community's persistent use of the "Whats UpDog?" meme, actively encouraging others to "Load UpDog" and participate in its Solana-based ecosystem, often celebrating other trending tokens with its namesake.

English version Introducing SWFTCoin (SWFTC) $SWFTC: Powering SWFT Blockchain and AI Services (SWFTGPT)  SwftCoin ($SWFTC) is the native utility token driving SWFT Blockchain's AI-powered ecosystem, SWFTGPT, and the first ever AI token featured on Coinbase. SWFTGPT is also the first domain-specific LLM for crypto.  SwftCoin key features include: 50% Reduced Transaction Fees: Lower costs on all transactions. AI Service Payments: Use $SWFTC to access SWFTGPT. Tools include expert market analysis,  predictions, and intelligent trading solutions.  Membership Benefits: Unlock premium features and AI agent services within SWFTGPT. AI-Powered Swaps: Enable precise, fast cross-chain transactions and analytics. SWFT Blockchain combines AI innovation with blockchain infrastructure, simplifying crypto trading while enhancing functionality through $SWFTC.   Chinese version $SWFTC：驱动 SWFT Blockchain 和 AI 服务（SWFTGPT） SwftCoin ($SWFTC) 是 SWFT Blockchain 的原生实用代币，为其 AI 驱动的生态系统 SWFTGPT 提供支持，同时也是 Coinbase 上首个 AI 代币。SWFTGPT 也是首个专注于加密领域的特定领域大型语言模型 (LLM)。 SwftCoin 的主要功能包括： 1、50% 交易费减免：降低所有交易成本。 2、AI 服务支付：使用 $SWFTC 访问 SWFTGPT 工具，包括专家市场分析、预测以及智能交易解决方案。 3、会员权益：解锁 SWFTGPT 的高级功能和 AI 代理服务。 4、AI 驱动的闪兑：实现精准快速的跨链交易和数据分析。 SWFT Blockchain 将 AI 创新与区块链基础设施结合，通过 $SWFTC 简化加密交易，并提升其功能性。

SwftCoin

SwftCoin ($SWFTC) is trending as the community anticipates a significant price surge, fueled by its recent availability to New York residents on Coinbase and its status as an AI-integrated cross-chain exchange with a fully diluted supply. Many holders are recalling past explosive gains and actively encouraging widespread attention, believing it to be an undervalued utility token poised for another major run amidst discussions of broader crypto market developments and asset tokenization.

Cooper-Standard Holdings, Inc. engages in the manufacture of sealing and fluid handling systems, including fuel and brake delivery and fluid transfer systems. It operates through the following segments: Sealing Systems, Fluid Handling Systems, and Corporate, Eliminations and Other. The Sealing Systems segment consists of manufacturing products for interior vehicle protection, dust and noise intrusion. The Fluid Handling Systems segment includes products that help convey, connect, control, and communicate throughout the fluid systems. The Corporate, Eliminations and Other segment is for all other business activities. The company was founded in 2004 and is headquartered in Northville, MI.

Cooper-Standard Holdings Inc

Cooper-Standard Holdings is trending due to a fundamentally strong earnings report and positive 2026 outlook, fueled by robust operational performance and significant new business wins in EV and hybrid platforms. The community is actively discussing the company's clear growth trajectory and potential for sustained margin expansion within the evolving automotive sector.

NextEra Energy, Inc. engages in the provision of renewable energy. It operates through the following segments: FPL and NEER. The FPL segment involves the generation, transmission, distribution, and sale of electric energy in Florida. The NEER segment produces electricity from clean and renewable sources, including wind and solar. The company was founded on December 28, 1925 and is headquartered in Juno Beach, FL.

NextEra Energy Inc

NextEra Energy is trending as its strategic partnerships with tech giants like Google and Meta position it at the forefront of powering AI data centers, a critical driver of surging electricity demand. The community is actively debating its long-term growth potential and perceived undervaluation amidst strong clean energy initiatives, despite recent mixed earnings results.

Fartcoin is a meme-driven cryptocurrency where users can submit their best fart jokes or memes to earn initial tokens. Each transaction triggers a hilarious 'Gas Fee' effect, complete with a digital fart sound for maximum comedic impact.

Fartcoin

Fartcoin is trending following its Coinbase listing, sparking intense debate among crypto enthusiasts; some foresee significant upside as a top memecoin, while others dismiss it as a "shitcoin" ripe for a dump.

Venice boasts an innovative approach to generative AI with its unique privacy architecture, access to competitive features including multiple leading open-source LLM models such as DeepSeek R1, PDFs analysis, and image and code generation. An unrestricted AI Characters feature is available with its Pro version, Venice Pro.   VVV is designed to minimize friction and reduce costs for AI agents and developers to access private, reliable, on-demand and perpetual AI inference via Venice.ai's API.

Venice Token

Venice Token (VVV) is experiencing significant community attention following substantial token burns and the rollout of new features like video generation and DIEM token minting. Enthusiastic discussions highlight its low circulating supply, attractive staking rewards, and unique private AI utility, particularly after recent exchange listings.

Dakota Gold Corp. operates as a gold exploration and development company. It is focused on new gold discoveries and opportunities that build on the legacy of the Homestake District. The company was founded in 2017 is headquartered in Lead, SD.

Dakota Gold Corp

Dakota Gold Corp. is gaining attention following recent high-grade drill results and resource expansion at its Richmond Hill and Maitland projects in the historic Homestake District, further bolstered by a strategic capital raise and investment. The community is actively debating the substantial exploration upside and favorable analyst outlook, while acknowledging short-term price volatility despite a strong gold market.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Immix Biopharma (NASDAQ:IMMX) Rating Increased to Hold at Wall Street Zen

Wall Street Zen raised Immix Biopharma from a "sell" rating to a "hold" rating in a research report on Saturday...

Immix Biopharma (IMMX) Shares Slip As Investors Focus On Plans To Offer And Sell $750 Million In Securities

Immix Biopharma Inc (NASDAQ: IMMX) shares are trading lower Monday after the company filed a new shelf registration statement.read more...

Immix Biopharma, Inc. (NASDAQ:IMMX) Short Interest Up 27.5% in December

Immix Biopharma, Inc. (NASDAQ:IMMX - Get Free Report) was the target of a large growth in short interest in the month of December. As of December 15th, there was short interest totaling 1,746,822...

Immix Biopharma (NASDAQ:IMMX) Stock Rating Upgraded by Wall Street Zen

Wall Street Zen upgraded Immix Biopharma from a "sell" rating to a "hold" rating in a research note on Saturday...

FY2025 EPS Estimates for Immix Biopharma Lifted by Analyst

Immix Biopharma, Inc. (NASDAQ:IMMX - Free Report) - Equities research analysts at HC Wainwright increased their FY2025 earnings estimates for Immix Biopharma in a research report issued on Tuesday...

<ul class="summary-bullets"><li>US equities look to extend last week’s gains.</li><li>Market-based odds now show an 87% chance of a rate cut.</li><li>Retail sentiment on Stocktwits, however, remains bearish on SPY and QQQ.</li></ul>U.S. stock futures inched higher in early Monday trade, as the market looks to build on gains from the previous week. All eyes will be on the highly anticipated Federal Reserve policy statement and press conference later in the week.&nbsp;According to the<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.cmegroup.com/markets/interest-rates/cme-fedwatch-tool.html">&nbsp;CME FedWatch tool</a>, the market is now pricing in an 87% chance of an interest rate cut this Wednesday, sharply higher than the 66% bets a month earlier.As of 3:00 a.m., ET on Monday, the Nasdaq 100 futures and S&amp;P 500 futures were up 0.2%, the Russell 2000 futures gained 0.3%, while the Dow futures were flattish with a positive bias. On Stocktwits, however, retail sentiment toward the&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF (SPY)</a>, an exchange-traded fund that tracks the S&amp;P 500 Index, and that toward the&nbsp;<a href="https://stocktwits.com/symbol/QQQ">Invesco QQQ Trust (QQQ)</a> ETF, which tracks the Nasdaq 100 Index, remained ‘bearish’ early Monday.&nbsp;<h2 class="st-heading-2">Stocks On Trending Watchlist&nbsp;</h2>Netflix (NFLX) and Warner Bros Discovery (WBD)&nbsp;remain in focus following the massive M&amp;A deal and potential regulatory overhang, including concerns raised by&nbsp;U.S. President Trump.Confluent (CFLT) is trending amid <a href="https://stocktwits.com/news-articles/markets/equity/why-ibm-may-want-confluent-3-charts-reveal-ai-play-s-promise/cLIYjkHREll">reports</a> of a potential&nbsp;$11-billion acquisition by IBM.&nbsp;Boeing (BA) is seeing retail chatter due to the impending close of the Spirit AeroSystems deal.Workhorse (WKHS)&nbsp;is on traders’ radar ahead of a 1-for-12 reverse split that takes effect on Dec 8.&nbsp;Eli Lilly (LLY), Pfizer (PFE), and Johnson &amp; Johnson (JNJ) have secured spots on China's drug catalog, with a total of 19 medicines making the list, according to a Bloomberg report.&nbsp;Immix Biopharma (IMMX) has priced an $100 million public offering via common stock and warrants, mainly to finance the development of its drug NXC-201.Oracle (ORCL) gains traction ahead of its earnings release on&nbsp;Dec. 10.&nbsp;Coreweave (CRWV) is also on the retail radar.&nbsp;Other companies reporting earnings this week are Adobe (ADBE), Broadcom (AVGO), Costco (COST), and Lululemon (LULU).<h2 class="st-heading-2">Key Catalysts To Watch Out For</h2>On the economic front, the big market mover will be the upcoming Fed meeting on December 9-10. No major data is scheduled&nbsp;for release today.&nbsp;And on the earnings front, investors will be watching for Toll Brothers, AlphaTON Capital, among others.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.

 Nasdaq, S&P 500 Futures Rise Ahead Of Fed Decision This Week: Why NFLX, CFLT, BA, LLY, IMMX Are On Traders' Radar

Market-based odds now show an 87% chance of a rate cut.

Equity

Immix Biopharma (NASDAQ:IMMX) Trading 4.5% Higher - What's Next?

Immix Biopharma (NASDAQ:IMMX) Shares Up 4.5% - What's Next...

HC Wainwright Reduces Earnings Estimates for Immix Biopharma

Immix Biopharma, Inc. (NASDAQ:IMMX - Free Report) - Research analysts at HC Wainwright cut their FY2025 earnings per share (EPS) estimates for shares of Immix Biopharma in a research report issued on...

Immix Biopharma (NASDAQ:IMMX) Announces Earnings Results, Misses Expectations By $0.05 EPS

Immix Biopharma (NASDAQ:IMMX - Get Free Report) announced its quarterly earnings data on Friday. The company reported ($0.24) earnings per share (EPS) for the quarter, missing the consensus estimate...

Immix Biopharma (IMMX) Upgraded to Buy: What Does It Mean for the Stock?

Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.

Immix Biopharma Inc

3%+ above current levels

Up 0–3%

Flat to down 3%

Down 3%+

The Nasdaq 100 continues to hinge on mega-cap tech and AI strength. With rate expectations shifting and valuations stretched, even a 3% move could signal a bigger trend. Is momentum building, or fading?

Stocktwits

Stocktwits Polls

Discussions highlight NXC-201's unique position as a de-risked asset, first-to-market CAR-T for AL amyloidosis, backed by FDA Breakthrough and RMAT designations.

Buzz centers on aggressive price targets, ranging from $8 to $20, driven by strong technicals like a Golden Cross and expectations of a short squeeze.

IMMX
Immix Biopharma Inc

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest IMMX News

IMMXImmix Biopharma Inc